David Whynes - Publications

School of Economics University of Nottingham, Nottingham, England, United Kingdom 

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Sampson C, James M, Whynes D, Eleuteri A, Harding S. OP60 Optimising Risk-Based Screening: The Case Of Diabetic Eye Disease International Journal of Technology Assessment in Health Care. 34: 21-21. DOI: 10.1017/S0266462318001046  0.536
2016 Whynes D, Duffy SW, Baldwin DR, Devaraj A, Field JK. Abstract 3458: UK lung cancer screening trial (UKLS) cost effectiveness: similarities with the NLST high-risk quintiles Cancer Research. 76: 3458-3458. DOI: 10.1158/1538-7445.Am2016-3458  0.432
2016 Whynes D, Sach T. Sex, benevolence and willingness to pay for screening International Journal of Social Economics. 43: 982-997. DOI: 10.1108/Ijse-09-2014-0192  0.327
2015 Sharp L, Cotton S, Cruickshank M, Gray N, Smart L, Whynes D, Little J. Impact of post-colposcopy management on women's long-term worries: results from the UK population-based TOMBOLA trial. The Journal of Family Planning and Reproductive Health Care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists. PMID 26376822 DOI: 10.1136/Jfprhc-2015-101170  0.338
2013 Duffy SW, Mackay J, Thomas S, Anderson E, Chen TH, Ellis I, Evans G, Fielder H, Fox R, Gui G, Macmillan D, Moss S, Rogers C, Sibbering M, Wallis M, ... ... Whynes D, et al. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technology Assessment (Winchester, England). 17: vii-xiv, 1-95. PMID 23489892 DOI: 10.3310/Hta17110  0.308
2013 Field JK, Baldwin D, Devaraj A, Brain K, Eisen T, Holemans J, Ledson M, Screaton N, Rintoul RC, Yadegarfar G, Hands C, McRonald FE, Lifford K, Whynes D, Kerr K, et al. Abstract 3631: United Kingdom lung cancer screening trial (UKLS): First 88897 approaches. Cancer Research. 73: 3631-3631. DOI: 10.1158/1538-7445.Am2013-3631  0.382
2012 Sharp L, Cotton S, Thornton A, Gray N, Cruickshank M, Whynes D, Duncan I, Hammond R, Smart L, Little J. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 165: 318-25. PMID 22921577 DOI: 10.1016/J.Ejogrb.2012.08.001  0.309
2011 Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Williamson P, Whynes D. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Thorax. 66: 736-7. PMID 21724746 DOI: 10.1136/Thoraxjnl-2011-200351  0.381
2011 Field JK, Duffy S, Baldwin D, Brain KE, Eisen T, Hands CJD, Kerr KM, Page R, Parmar M, Wald N, Weller D, Whynes D, Williamson P, Hansell D. United Kingom lung cancer screening (UKLS) trial [Conference abstract] Journal of Thoracic Oncology. DOI: 10.1097/01.Jto.0000399290.73317.Eb  0.329
2005 Frew EJ, Wolstenholme JL, Whynes DK. Eliciting relative preferences for two methods of colorectal cancer screening. European Journal of Cancer Care. 14: 124-31. PMID 15842459 DOI: 10.1111/J.1365-2354.2005.00515.X  0.347
2003 Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. International Journal of Technology Assessment in Health Care. 19: 384-95. PMID 12862195 DOI: 10.1017/S0266462303000345  0.3
2001 Philips Z, Whynes D, Parnham S, Slack R, Earwicker S. The role of community pharmacists in prescribing medication for the treatment of head lice. Journal of Public Health Medicine. 23: 114-20. PMID 11450927 DOI: 10.1093/Pubmed/23.2.114  0.327
2001 Frew E, Wolstenholme J, Whynes D. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test. Journal of Health Services Research & Policy. 6: 85-91. PMID 11357249 DOI: 10.1258/1355819011927279  0.371
2000 Avery AJ, Rodgers S, Heron T, Crombie R, Whynes D, Pringle M, Baines D, Petchey R. A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs. Bmj. 321: 276-281. PMID 10915132 DOI: 10.1136/Bmj.321.7256.276  0.317
2000 Miller P, Whynes D, Reid A. An economic evaluation of occupational health. Occupational Medicine (Oxford, England). 50: 159-63. PMID 10912357 DOI: 10.1093/Occmed/50.3.159  0.309
1998 Baines D, Whynes D. The use of the ASTRO-PU and the ASTRO(97)-PU in the setting of prescribing budgets in English general practice. Journal of Clinical Pharmacy and Therapeutics. 23: 229-234. PMID 9831975 DOI: 10.1046/J.1365-2710.1998.00157.X  0.301
1997 Wolstenholme J, Whynes D. OP32. The cost of cervical cancer: Implications for screening European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85912-6  0.382
1997 Wolstenholme J, Whynes D. OP31. The cost of breast cancer: Implications for screening European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85911-4  0.349
1997 Whynes D, Walker A, Neilson A. OP30. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85910-2  0.381
1993 Whynes D, Walker A, Chamberlain J, Hardcastle J. Screening and the costs of treating colorectal cancer. British Journal of Cancer. 68: 965-968. PMID 8217610 DOI: 10.1038/Bjc.1993.462  0.393
Show low-probability matches.